High Volatility, High Reward: Two Biotech Stocks for the Risk-Tolerant Investor Mar 26, 2026 Life Science
Eli Lilly’s Weight-Loss Bet Comes With Risk. This ETF Offers a Smarter Alternative Mar 25, 2026 Life Science
April 10 Looms as Eli Lilly’s Next Big Test: Is the Stock a Buy Before the FDA Verdict? Mar 22, 2026 Life Science
Hims & Hers Joins Hands with Former Rival, Hidden Concerns Loom Over the Weight Loss Drug Market Landscape Mar 18, 2026 Life Science
How is Pfizer Tackling the “Blockbuster Drug Drought” in the Post-Pandemic Era? Mar 17, 2026 Life Science
Insider Cashes Out, Hedge Fund Piles In: The Two Faces of Olema After a 300% Rally Mar 16, 2026 Life Science
Three Berkshire-Related Stocks Worth Watching: Chevron, Domino’s Pizza, and DaVita Mar 14, 2026 Consumer Goods, Life Science
Novo Nordisk Partners with Hims & Hers: Can Turning a Foe into a Friend Reverse the Downturn? Mar 13, 2026 Life Science
